Skip to main content
. Author manuscript; available in PMC: 2014 Jan 12.
Published in final edited form as: Pediatr Res. 2012 Jul 20;72(4):375–383. doi: 10.1038/pr.2012.96

Figure 4.

Figure 4

Lung inflammatory profile. Total and regional lung tissue levels of (a,b) IL-8; (c,d) IL-6; (e,f) MPO. For (b), (d), and (f), open bars are nondependent, solid bars are dependent lung. Independent of lung region, all were lower (*P < 0.01) following lucinactant treatment as compared with no surfactant treatment. Lung IL-8 following lucinactant treatment was also lower (**P < 0.01) than following treatment with beractant, and those treated with poractant alfa also had lower lung IL-8 (*P < 0.05) than did negative controls, independent of region. Lung IL-6 following lucinactant treatment was lower (*P < 0.01) than in all other groups, independent of region. Lung MPO was lower (*P < 0.01) following lucinactant or beractant treatment as compared with negative controls, independent of region. IL, interleukin; MPO, myeloperoxidase.